Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PAPAVERINE vs PARICALCITOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PAPAVERINE vs PARICALCITOL: Safety Overview

Metric PAPAVERINE PARICALCITOL
Total FAERS Reports 341 6,665
Deaths Reported 196 4,801
Death Rate 57.5% 72.0%
Hospitalizations 89 1,662
Average Patient Age 53.4 yrs 57.8 yrs
% Female Patients 43.4% 43.1%
FDA Approval Date N/A Apr 17, 1998
Manufacturer American Regent, Inc. Aurobindo Pharma Limited
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription